Meclizine Hydrochloride
NDC 16571-662, Meclizine Hydrochloride, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-662
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA010721
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-662 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MECLIZINE HYDROCHLORIDE50 mg/1
Pharmacologic classes
Antiemetic [EPC]; Emesis Suppression [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-662-01 | 16571066201 | 100 TABLET in 1 BOTTLE (16571-662-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c9ddc39c-bc6b-42f1-8c5f-5aff2d79c4bdNADAC price for package 16571066201
GET /v1/drugs/nadac/16571066201
Use it
Look up 16571-662 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-662 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-662. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.